2171 — CARsgen Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$3.14bn
- HK$1.23bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -265 | -1,064 | -4,737 | -891 | -747 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 37.8 | 715 | 4,155 | 125 | -24.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 28.7 | 14.2 | 16.9 | 41.7 | 230 |
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -179 | -295 | -512 | -643 | -455 |
Capital Expenditures | -103 | -18.7 | -178 | -139 | -9.55 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 186 | 11.8 | -2,293 | 2,526 | 48.8 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 83 | -6.9 | -2,471 | 2,387 | 39.3 |
Financing Cash Flow Items | -0.712 | 1,270 | -32.3 | -5.36 | -4.78 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 27.5 | 1,302 | 2,674 | -237 | -22.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -67.1 | 946 | -352 | 1,577 | -418 |